Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors

Fig. 1

Validation of proteins using MRM assay to understand the segregation of Meningioma grades in the Tissue sample. (1A) Schematic outline of setting up of targeted proteomics of Tissue samples. (1B) QC Profile plot of all the peptides in the Pool samples to decipher the integrity and stability of the assay in intra and inter-day comparison, (1C) LDA score-based clustering depicting the segregation of the sample groups; (1D-F) represents the peaks and expression of S100A11, PFN1, and PLEC using profile plot between High-Grade Meningioma vs. Low-Grade tissue samples

Back to article page

Clinical Proteomics

ISSN: 1559-0275